48 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
, before expenses, to us
Underwriting discounts and commissions do not include the reimbursement of certain expenses of the underwriter we have agreed
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
and commissions do not include the reimbursement of certain expenses of the underwriter we have agreed to pay. See “Underwriting” for a description
8-K
EX-10.1
tu8l6bltnhmx1ptblyur
1 May 23
Departure of Directors or Certain Officers
7:30am
S-3
6br01 98vpw
23 Dec 22
Shelf registration
4:16pm
8-K
EX-1.1
1r1 3txvjls
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
tr71d x96g
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
g1ps9i3z2kvs9m 4zg58
20 Oct 22
Draft registration statement
12:00am